12
24
30
36
46
e E d i t i o n : M a y / J u n e 2 0 2 4 - : I s s u e 3 - Vo l u m e 5
CHIEF EDITOR Rahul Koul
EDITORIAL Sachin Arya Special Correspondent
Vaishnavi Srivastava Reporter
Brijesh Kumar News Desk
Shanu K Art Direction & Cartoon
BUSINESS HEAD Bhaskar Jha
OPERATIONS Arvind Kumar Executive Oprations
Barun Dey Admin Executive
For advertinsing & marketing write to us : advertising @ biovoicenews . com
Disclaimer : Views and opinions expressed in this e- magazine are not necessarily those of BioVoice News and its publisher PetriDish Media Pvt . Ltd . and / or editors . We , at PetriDish Media Pvt . Ltd . do our best to verify the information published , but do not take responsibility for the absolute accuracy of the information contained in this publication . PetriDish Media Pvt . Ltd . does not accept responsibility for any business or any other decisions taken by the readers on the basis of the information provided herein . All rights reserved . No part of this publication should be reproduced by any means without the written permission from the publisher . Published by : PetriDish Media Pvt . Ltd ., B-1 / 6 , LGF , Hauz Khas , New Delhi – 110016 , INDIA
12
24
30
36
46
COVER STORY
Lok Sabha Elections 2024
Reality Check : Can Bioscience be a relevant issue for Poll Agenda ?
In the absence of bipartisan support , bioscience fails to garner the attention it deserves on the poll agenda . Encouraging dialogue and awareness on the potential of the sector for addressing national priorities could help its integration into India ' s political discourse
INTERVIEW
Ramesh Raju , Head – Validations Services , Merck Life Science India explains the latest scenario in validation services within biopharma industry and his company ’ s offerings
EXPERT INSIGHTS
Rise of Biopharmaceuticals in India
Jai Raj , Country Manager-India , Biotage explains why and how Indian biotech companies , both established giants and nimble startups , are investing heavily in research and development
EXPERT INSIGHTS
Genome Valley : Asia ’ s Premier Preclinical Research Hub
Vishal Goel Managing Director , Rx Propellant shares insights on how support from both the government and private sector , has propelled GV to the forefront of preclinical research in Asia
EXPERT INSIGHTS
Recognizing suspicious medications critical to combat counterfeit cancer drugs
04
BioVoiceNews | May / June 2024